Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022

SELL
$0.13 - $0.28 $19 - $41
-148 Reduced 74.0%
52 $0
Q2 2022

Aug 03, 2022

BUY
$0.21 - $0.38 $42 - $76
200 New
200 $0
Q1 2022

May 02, 2022

SELL
$0.31 - $2.27 $1,212 - $8,880
-3,912 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$2.01 - $4.08 $7,863 - $15,960
3,912 New
3,912 $8,000

Others Institutions Holding STAB

About Statera Biopharma, Inc.


  • Ticker STAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,295,700
  • Description
  • Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...
More about STAB
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.